术前炎性指标评估喉癌复发的临床意义
The Clinical Significance of Preoperative Inflammatory Indexes in Evaluating the Recurrence of Laryngeal Carcinoma
摘要: 目的:探讨术前中性粒细胞、淋巴细胞、单核细胞、血小板、中性粒细胞淋巴细胞比率(NLR)、血小板淋巴细胞比率(PLR)、淋巴细胞单核细胞比率(LMR)与喉鳞状细胞癌复发的关联及临床意义。方法:对在青岛大附属医院初次手术治疗的196例喉鳞状细胞癌患者进行回顾性研究,收集符合标准患者的临床数据及炎性指标数据,炎性指标数据用均数 ± 标准差(x ± s)表示,采用t检验和单因素方差分析或者Mann-Whitney U秩和检验和Kruskal-Wallis检验分析炎性指标与喉癌复发的关联。结果:单一性炎性指标中,仅淋巴细胞与喉癌的复发存在统计学意义(P < 0.01),在复合性炎症指标中,NLR、PLR、LMR都是显著影响喉癌复发的因素(P < 0.01)。淋巴结转移、T分期越大、临床分期越晚,NLR和PLR则越高,而LMR越低。结论:术前NLR、PLR升高以及淋巴细胞、LMR降低可用于预测喉癌的复发。
Abstract: Objective: To investigate the correlation and clinical significance of preoperative neutrophils, lymphocytes, monocytes, platelets, neutrophilto lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR) and recurrence of laryngeal squamous cell carcinoma (LSCC). Methods: A retrospective study was conducted on 196 patients with laryngeal squamous cell carcinoma who were treated for the first time in Qingdao University Hospital. The clinical data and inflammatory index data of patients meeting the standards were collected. The inflammatory index data was used as mean ± standard deviation (x ± s) means that the t-test and one-way analysis of variance or Mann-Whitney U rank sum test and Kruskal-Wallis test are used to analyze the association between inflammatory indicators and the recurrence of laryngeal cancer. Results: Among the single inflammatory indexes, only the recurrence of lymphocytes and laryngeal cancer was statistically significant (P < 0.01). Among the complex inflammatory indexes, NLR, PLR, and LMR were all significant factors affecting the recurrence of laryngeal cancer (P < 0.01). Lymph node metastasis, the larger the T stage, the later the clinical stage, result of the higher the NLR and PLR, and the lower the LMR. Conclusion: Preoperative increase in NLR or PLR and decrease in lymphocytes or LMR can be used to predict the recurrence of laryngeal cancer.
文章引用:唐艳珍, 王得力, 赵修凯, 邱杰. 术前炎性指标评估喉癌复发的临床意义[J]. 临床医学进展, 2021, 11(2): 755-762. https://doi.org/10.12677/ACM.2021.112108

参考文献

[1] Pan, X.L. and Lin, Y. (2020) The Correct Selection of Treatment Strategies for Laryngeal Cancer to Improve the Survival Rate and Quality of Life for Patients. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 55, 1111-1115.
[2] 陈文杰, 王斌全, 高伟, 等. 喉癌流行病学特征及影响因素分析[J]. 中国当代医药, 2015, 22(12): 43-46.
[3] 魏矿荣, 郑荣寿, 梁智恒, 等. 2014年中国喉癌发病与死亡分析[J]. 中华肿瘤杂志, 2018, 40(10): 736-743.
[4] Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef
[5] Coussens, L.M. and Werb, Z. (2002) Inflammation and Cancer. Nature, 420, 860-867. [Google Scholar] [CrossRef] [PubMed]
[6] Dolan, R.D., et al. (2017) The Role of the Systemic Inflammatory Response in Predicting Outcomes in Patients with Operable Cancer: Systematic Review and Meta-Analysis. Scientific Reports, 7, Article No. 16717. [Google Scholar] [CrossRef] [PubMed]
[7] Roxburgh, C.S.D. and McMillan, D.C. (2010) Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer. Future Oncology, 6, 149-163. [Google Scholar] [CrossRef] [PubMed]
[8] Zanoni, D.K., Patel, S.G. and Shah, J.P. (2019) Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications. Current Oncology Reports, 21, 52. [Google Scholar] [CrossRef] [PubMed]
[9] Hsueh, C., et al. (2017) The Prognostic Value of Preoperative Neutrophils, Platelets, Lymphocytes, Monocytes and Calculated Ratios in Patients with Laryngeal Squamous Cell Cancer. Oncotarget, 8, 60514-60527. [Google Scholar] [CrossRef] [PubMed]
[10] Kara, M., et al. (2017) The Pre-Treatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Red Cell Distribution Width Predict Prognosis in Patients with Laryngeal Carcinoma. European Archives of Oto-Rhino- Laryngology, 274, 535-542. [Google Scholar] [CrossRef] [PubMed]
[11] Dumitru, C.A., Lang, S. and Brandau, S. (2013) Modulation of Neutrophil Granulocytes in the Tumor Microenvironment: Mechanisms and Consequences for Tumor Progression. Seminars in Cancer Biology, 23, 141-148. [Google Scholar] [CrossRef] [PubMed]
[12] Shacter, E. and Weitzman, S.A. (2002) Chronic Inflammation and Cancer. Oncology (Williston Park), 16, 217-226.
[13] Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444. [Google Scholar] [CrossRef] [PubMed]
[14] Bambace, N.M. and Holmes, C.E. (2011) The Platelet Contribution to Cancer Progression. Journal of Thrombosis and Haemostasis, 9, 237-249. [Google Scholar] [CrossRef] [PubMed]
[15] Sylman, J.L., Mitrugno, A., Tormoen, G.W., Wagner, T.H., Mallick, P. and McCarty, O.J.T. (2017) Platelet Count as a Predictor of Metastasis and Venous Thromboembolism in Patients with Cancer. Convergent Science Physical Oncology, 3, Article ID: 023001. [Google Scholar] [CrossRef] [PubMed]
[16] McCarty, O.J., Mousa, S.A., Bray, P.F. and Konstantopoulos, K. (2000) Immobilized Platelets Support Human Colon Carcinoma Cell Tethering, Rolling, and Firm Adhesion under Dynamic Flow Conditions. Blood, 96, 1789-1797. [Google Scholar] [CrossRef
[17] Goubran, H.A., Burnouf, T., Radosevic, M. and El-Ekiaby, M. (2013) The Platelet-Cancer Loop. European Journal of Internal Medicine, 24, 393-400. [Google Scholar] [CrossRef] [PubMed]
[18] Hu, Y.C., Yi, Z.J., Zhou, Y., et al. (2017) Overexpression of RIP140 Suppresses the Malignant Potential of Hepatocellular Carcinoma by Inhibiting NFkappaB Mediated Alternative Polarization of Macrophages. Oncology Reports, 37, 2971-2979. [Google Scholar] [CrossRef] [PubMed]
[19] 束青华, 张楠楠, 韩建波, 易永祥, 张郁峰. 淋巴细胞与单核细胞比值在肝细胞癌患者中的预后价值分析[J]. 中国普通外科杂志, 2020, 29(7): 867-876.
[20] Chen, L., et al. (2018) Survival and Prognostic Analysis of Preoperative Inflammatory Markers in Patients Undergoing Surgical Resection for Laryngeal Squamous Cell Carcinoma. BMC Cancer, 18, 816. [Google Scholar] [CrossRef] [PubMed]
[21] Zhong, B., et al. (2018) May the Change of Platelet to Lymphocyte Ratio Be a Prognostic Factor for T3-T4 Laryngeal Squamous Cell Carcinoma: A Retrospective Study. PLoS ONE, 13, e0210033. [Google Scholar] [CrossRef] [PubMed]
[22] Sumner, W.A., et al. (2017) Survival Impact of Pre-Treatment Neutrophils on Oropharyngeal and Laryngeal Cancer Patients Undergoing Definitive Radiotherapy. Journal of Translational Medicine, 15, 168. [Google Scholar] [CrossRef] [PubMed]
[23] Seckin, K.D., Karsli, M.F., Yucel, B., Bestel, M., Yildirim, D., Canaz, E., et al. (2016) The Utility of Tumor Markers and Neutrophil Lymphocyte Ratio in Patients with an Intraoperative Diagnosis of Mucinous Borderline Ovarian Tumor. European Journal of Obstetrics & Gynecology and Reproductive Biology, 196, 60-63. [Google Scholar] [CrossRef] [PubMed]
[24] Kum, R.O., et al. (2014) Elevated Neutrophil-to-Lymphocyte Ratio in Squamous Cell Carcinoma of Larynx Compared to Benign and Precancerous Laryngeal Lesions. Asian Pacific Journal of Cancer Prevention, 15, 7351-7355. [Google Scholar] [CrossRef